Pulmonary Hypertension News and Research

RSS
Pulmonary arterial hypertension (PAH) is a condition involving high blood pressure and structural changes in the walls of the pulmonary arteries, which are the blood vessels that connect the right side of the heart to the lungs. Affecting people of all ages and ethnic backgrounds - but most commonly found in young women of child-bearing years - the disease has historically been chronic and incurable, with a poor survival rate. PAH is often not diagnosed in a timely manner because its early symptoms can be confused with those of many other pulmonary and respiratory conditions. Symptoms include shortness of breath, extreme fatigue, dizziness, fainting, swollen ankles and legs and chest pain (especially during physical activity). With proper diagnosis, there are currently several therapies to alleviate symptoms and improve quality of life for PAH patients. The key is to find a PAH specialist and pursue immediate treatment.
New partnership to advance novel airway-delivered gene therapy for treating pulmonary hypertension

New partnership to advance novel airway-delivered gene therapy for treating pulmonary hypertension

Scientists develop first app and method to predict heart events after liver transplant

Scientists develop first app and method to predict heart events after liver transplant

New chemoprevention trial hopes to stop dangerous lesions from progressing to cancer

New chemoprevention trial hopes to stop dangerous lesions from progressing to cancer

Drug treatment used for other conditions can help women combat urinary incontinence

Drug treatment used for other conditions can help women combat urinary incontinence

CT-measured vascular pruning linked to mortality risk in smokers without COPD

CT-measured vascular pruning linked to mortality risk in smokers without COPD

Study finds high and growing prevalence of women with heart disease delivering babies

Study finds high and growing prevalence of women with heart disease delivering babies

AATS guidelines offer clear recommendations for treating ischemic mitral regurgitation

AATS guidelines offer clear recommendations for treating ischemic mitral regurgitation

Growth factors in cord blood may help identify preemies at risk for fatal lung disease

Growth factors in cord blood may help identify preemies at risk for fatal lung disease

Researchers reveal how inflammatory responses block fat cell conversion

Researchers reveal how inflammatory responses block fat cell conversion

New treatment may reduce side effects linked to transfusions of red blood cells

New treatment may reduce side effects linked to transfusions of red blood cells

Climbing Mount Kilimanjaro to research oxygen deprivation

Climbing Mount Kilimanjaro to research oxygen deprivation

Study provides insight into how weight-loss drug acts in the brain

Study provides insight into how weight-loss drug acts in the brain

ESC releases novel position paper on tackling cardiotoxicity of anticancer treatments

ESC releases novel position paper on tackling cardiotoxicity of anticancer treatments

Experts develop new genomic testing method for pulmonary hypertension caused by genetic mutation

Experts develop new genomic testing method for pulmonary hypertension caused by genetic mutation

Disordered airway microbiome at birth may be linked to severe neonatal lung disease

Disordered airway microbiome at birth may be linked to severe neonatal lung disease

Testing lung health online: an interview with Professor Stephen Holgate

Testing lung health online: an interview with Professor Stephen Holgate

Study provides key insights for effective treatment of individuals with HFpEF

Study provides key insights for effective treatment of individuals with HFpEF

UAB receives NIH grants in three perinatal networks to improve maternal and infant health

UAB receives NIH grants in three perinatal networks to improve maternal and infant health

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Circulating angiogenic factor shows PAH biomarker potential

Circulating angiogenic factor shows PAH biomarker potential